Multiple Sclerosis
MS Briefs
Impact of polypharmacy in RRMS
MS Briefs
Algorithms help identify RRMS patients
Clinical Topics & News
Interview with Clyde E. Markowitz, MD on switching therapies during MS treatment
News
FDA approves diroximel fumarate for relapsing MS
The oral drug, marketed as Vumerity, converts to the same active metabolite as dimethyl fumarate.
MS Briefs
Investigators Use ARMSS Score to Predict Future MS-related Disability
MS Briefs
Smoking Impairs Cognition and Shrinks Brain Volume in MS
MS Briefs
Adolescent Lung Inflammation May Trigger Later MS
Conference Coverage
Adolescent lung inflammation may trigger later MS
STOCKHOLM – Swedish national health care registry studies show associations between pneumonia or infectious mononucleosis occurring in early...
Conference Coverage
Smoking impairs cognition and shrinks brain volume in MS
STOCKHOLM – New evidence suggests the damage may be partially reversible.
Conference Coverage
In patients with CIS, combined omics predicts conversion to clinically definite MS
STOCKHOLM – Oligoclonal band status is helpful for diagnosis, but cannot predict who will go on to develop clinically definite MS.